S21 - Epilepsy and Clinical Neurophysiology (EEG) I

Event Time: Tuesday April 25, 2017 1:00 pm to 3:00 pm
Topic(s): Epilepsy/Clinical Neurophysiology (EEG)
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox–Gastaut syndrome (LGS): results of a multi-center, randomized, double–blind, placebo controlled trial (GWPCARE4) Jacqueline French
Dr. French has received research support from Acorda, Alexza, Eisai Medical Research, LCGH, Lundbeck, Pfizer, SK Life Sciences, Sunovion, Takeda, and UCB.

1:12 PM 002 Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology - APE Study Divyanshu Dubey, MD
Dr. Dubey has nothing to disclose.

1:24 PM 003 Relationship between Cognitive Performance and Subjective Symptoms in Patients with Newly Diagnosed Focal Epilepsy Kimford Meador, MD, FAAN
Dr. Meador has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with the Epilepsy Study Consortium, Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma, and Vivus Pharmaceuticals. Dr. Meador has received research support from Sunovion.

1:36 PM 004 Long-term safety and efficacy of responsive brain stimulation in adults with medically intractable partial onset seizures Dileep Nair, MD
Dr. Nair has nothing to disclose.

2:00 PM 005 Post-Diagnosis Neurological Care for Patients with Psychogenic Nonepileptic Spells (PNES) Chloe Hill
Dr. Hill has nothing to disclose.

2:12 PM 006 To Reveal or Conceal? Adult Patient Perspectives on SUDEP Disclosure. Lucretia Long
Dr. Long has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lina Nova, Sunovion Pharmceuticals , and Supernus Pharmaceuticals.

2:24 PM 007 Antibodies to neuronal surface antigens in possible autoimmune encephalitis and new-onset refractory status epilepticus (NORSE) Takahiro Iizuka, MD
Dr. Iizuka has nothing to disclose.

2:36 PM 008 Chronic Cortical Electrode Stimulation is Effective for Focal Epilepsy Brian Lundstrom, MD
Dr. Lundstrom has nothing to disclose.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses